Bloodstream Infection Trends Before and After the COVID-19 Pandemic
International Journal of Current Pharmaceutical Review and Research · 30.04.2026 · 18 (04)
DOI: 10.25258/ijcpr.18.4.71 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.04.2026. Verfasst von Dipti Lal und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Background
The COVID-19 pandemic has had a substantial impact on the epidemiology of bloodstream infections (BSIs), as seen by the rising rates of infection and antibiotic resistance reported globally.
Aims
To examine patterns of antibiotic resistance, pathogen dispersion, and bloodstream infection trends prior to and during the COVID-19 pandemic.
Methods
Three thousand patients (1500 pre-COVID and 1500 post-COVID) participated in a retrospective cohort research in a tertiary care hospital in Bihar, India. Positivity rates, microbiological profiles, and antibiotic resistance were examined in blood culture data. SPSS and WHONET were used for statistical analysis, and p < 0.05 was deemed significant.
Results
Blood culture positive showed a growing trend over time, going from 28% pre-COVID to 34% postCOVID. Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa were the most frequently isolated gram-negative microbes. The post-COVID era saw a rise in infections linked to intensive care units. Antimicrobial resistance and multidrug-resistant (MDR) isolates increased significantly (from 35.7% to 47%). There was also a minor rise in Candida species-related fungal infections.
Conclusion
The study shows that bloodstream infections and antibiotic resistance have significantly increased in the post-COVID period, especially in intensive care units. To combat the rising incidence of BSIs and AMR, it is crucial to strengthen infection control protocols, antibiotic stewardship, and ongoing surveillance.
Zitieren
APA
Lal, D., Suman, S., Kumar, S., Kumar, R., Sagar, S., & Ahmad, W. (2026). Bloodstream Infection Trends Before and After the COVID-19 Pandemic. International Journal of Current Pharmaceutical Review and Research, 18(04). https://doi.org/10.25258/ijcpr.18.4.71
Vancouver
Lal D, Suman S, Kumar S, Kumar R, Sagar S, Ahmad W. Bloodstream Infection Trends Before and After the COVID-19 Pandemic. International Journal of Current Pharmaceutical Review and Research. 2026;18(04). doi:10.25258/ijcpr.18.4.71
BibTeX
@article{Lal2026,
author = {Lal, Dipti and Suman, Sushant and Kumar, Sanjay and Kumar, Rajesh and Sagar, Satyendu and Ahmad, Wasim},
title = {Bloodstream Infection Trends Before and After the COVID-19 Pandemic},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {04},
doi = {10.25258/ijcpr.18.4.71}
}
EUVIMED